Mkts

NovoCure Limited

NASDAQ: NVCR
$13.10-0.01 (-0.08%)
As of Oct 30, 12:32 PM ET

Key statistics

Day range
12.5213.13
52-week range
9.8221.45
Today
Open12.95
Previous close13.10
Volume—
Valuation
Market cap1.58B
P/E ratio—
EPS (TTM)-1.31
Income & risk
Dividend / yield—
Beta1.11
Avg volume1.50M
Discussion

NVCR News

Stories mentioning NVCR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue174,055174,350167,204158,805154,994161,266155,095150,356
Cost of Goods Sold38,92942,15744,72941,47238,52133,46635,37234,654
Gross Profit135,126132,193122,475117,333116,473127,800119,723115,702
Operating Expenses
Research & Development58,33660,90554,02955,83353,77751,21051,88254,955
Sales General & Admin
Total Operating Expenses202,546172,586158,496156,854154,338191,104151,815149,282
Operating Income (Loss)(67,420)(40,393)(36,021)(39,521)(37,865)(63,304)(32,092)(33,580)
Interest Income
Interest Expense
Other Expense
Pretax Income(69,258)(40,954)(30,022)(34,979)(30,295)(55,206)(21,585)(22,729)
Tax Provision1,880(16,455)7,2485,1604,02410,7168,98510,646
Net Income (Loss)(71,138)(24,499)(37,270)(40,139)(34,319)(65,922)(30,570)(33,375)
Earnings Per Share (Basic)(0.62)(0.22)(0.33)(0.36)(0.31)(0.61)(0.28)(0.31)
Earnings Per Share (Diluted)(0.62)(0.22)(0.33)(0.36)(0.31)(0.61)(0.28)(0.31)
Weighted Average Shares Outstanding (Basic)114,150111,472111,908111,572110,282107,834108,248107,700
Weighted Average Shares Outstanding (Diluted)114,150111,472111,908111,572110,282107,834108,248107,700

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NVCR

NovoCure Limited (NASDAQ: NVCR) is a stock listed on the Nasdaq Stock Market under the ticker symbol NVCR. It last traded at $13.10 (Oct 30, 2026, 12:32 PM ET), down 0.1% on the day. That gives NovoCure a market capitalisation of $1.6B.

Over the past 52 weeks NVCR has traded between $9.82 and $21.45.

Revenue for the quarter ended Mar 31, 2026 was $174.1M; a net loss of $71.1M. Revenue was up 12.3% from $155.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$174.1M-$71.1M-40.9%
Dec 31, 2025$174.4M-$24.5M-14.1%
Sep 30, 2025$167.2M-$37.3M-22.3%
Jun 30, 2025$158.8M-$40.1M-25.3%

From NovoCure’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…